Skip to main content
. 2025 Nov 27;16:1728721. doi: 10.3389/fphar.2025.1728721

TABLE 2.

Changes in CMAP amplitude decrement at baseline and 12 months in 11 patients undergoing low-frequency RNS.

Variable Baseline (%) 12 months (%) p-value
(n = 11) (n = 11)
Predominant nerve decrement 25.0 (20.0, 27.0) 14.0 (11.0, 17.0) 0.003
Mean three-nerve decrement 15.3 (11.3, 16.3) 9.3 (7.3, 11.7) 0.003

P-values from Wilcoxon signed-rank tests comparing baseline vs. 12 months.